Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1881-1886

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bengel, F. M.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bengel, F. M.
Right arrow Articles by Schwaiger, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Related Collections
Right arrow Nuclear cardiology and PET
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2001;103:1881.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Myocardial Efficiency and Sympathetic Reinnervation After Orthotopic Heart Transplantation

A Noninvasive Study With Positron Emission Tomography

Frank M. Bengel, MD; Peter Ueberfuhr, MD; Nina Schiepel, MS; Stephan G. Nekolla, PhD; Bruno Reichart, MD; Markus Schwaiger, MD

From Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München (F.M.B., N.S., S.G.N., M.S.) and Herzchirurgische Klinik der Ludwig-Maximilians Universität München (P.U., B.R.), Munich, Germany.

Correspondence to Frank M. Bengel, MD, Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar, Ismaninger Str 22, 81675 München, Germany. E-mail frank.bengel{at}lrz.tu-muenchen.de

Background—The lack of cardiac catecholamine uptake and storage caused by sympathetic denervation may influence performance of the transplanted heart. Reinnervation, occurring late after transplantation, may partially resolve these effects. In this study, oxidative metabolism and its relation to cardiac work were compared in allografts and normal and failing hearts, and the effects of sympathetic reinnervation were evaluated.

Methods and Results—Twenty-seven nonrejecting, symptom-free transplant recipients, 11 healthy control subjects, and 10 patients with severe dilated cardiomyopathy underwent PET with 11C acetate for assessment of oxidative metabolism by the clearance constant k(mono) and radionuclide angiography or MRI for measurement of ventricular function, geometry, and work. Efficiency was estimated noninvasively by a work-metabolic index [WMI=(stroke volumexheart ratexsystolic pressure)/k(mono)]. In 14 of 27 transplants, presence of regional reinnervation was identified with PET and the catecholamine analogue 11C hydroxyephedrine (extent, 24±14% of left ventricle). The WMI was comparable in normal subjects and reinnervated and denervated transplants (6.2±2.3 versus 4.9±2.0 versus 4.9±1.2 · 106 mm Hg · mL; P=NS) and significantly lower in cardiomyopathy patients (3.0±1.3 · 106 mm Hg · mL; P<0.001). For normal subjects and transplant recipients, the WMI was significantly correlated with afterload (peripheral vascular resistance; r=-0.65, P<0.01), preload (end-diastolic volume; r=0.78, P<0.01), and stroke volume (r=0.81, P<0.01) but not with hydroxyephedrine retention (transplants only; r=0.09, P=NS).

Conclusions—After transplantation, cardiac efficiency is improved compared with failing hearts and comparable to normal hearts. Differences between denervated and reinnervated allografts were not surveyed. Additionally, the dependency on loading conditions and contractility was preserved, suggesting that normal regulatory interactions for efficiency are intact and that sympathetic tone does not play a role under resting conditions.


Key Words: transplantation • myocardium • nervous system, sympathetic • tomography




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Fellet, A. M. Balaszczuk, C. Arranz, J. J. Lopez-Costa, A. Boveris, and J. Bustamante
Autonomic regulation of pacemaker activity: role of heart nitric oxide synthases
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1246 - H1254.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. M. Bengel, P. Ueberfuhr, J. Karja, K. Schreiber, S. G. Nekolla, B. Reichart, and M. Schwaiger
Sympathetic reinnervation, exercise performance and effects of {beta}-adrenergic blockade in cardiac transplant recipients
Eur. Heart J., October 1, 2004; 25(19): 1726 - 1733.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. M. Bengel, P. Ueberfuhr, T. Hesse, N. Schiepel, S. I. Ziegler, S. Scholz, S. G. Nekolla, B. Reichart, and M. Schwaiger
Clinical Determinants of Ventricular Sympathetic Reinnervation After Orthotopic Heart Transplantation
Circulation, August 13, 2002; 106(7): 831 - 835.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. M. Bengel, P. Ueberfuhr, N. Schiepel, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation
N. Engl. J. Med., September 6, 2001; 345(10): 731 - 738.
[Abstract] [Full Text] [PDF]